Retrospective analysis of the long-term therapeutic effectiveness and safety profile of rituximab in the treatment of mucous membrane pemphigoid in a German university center between 2008 and 2019

Retrospective analysis of the long-term therapeutic effectiveness and safety profile of rituximab in the treatment of mucous membrane pemphigoid in a German university center between 2008 and 2019

BackgroundThe B-cell-depleting anti-CD20 antibody rituximab (RTX) is often used as an adjuvant drug for the treatment of refractory cases of mucous membrane pemphigoid (MMP).ObjectiveThis study aims to determine the therapeutic effectiveness and the safety profile of RTX in MMP.MethodsThe medical re...

Full description

Bibliographic Details
Main Authors: Florian Bamberger, Inke R. König, Damian Gola, Detlef Zillikens, Christian D. Sadik
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Immunology
Subjects:
mucous membrane pemphigoid
rituximab
pemphigoid disease
autoantibodies
side-effects
B cell depletion
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1180150/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1180150/full

Similar Items